HIV Combination Prevention Training Program

T32 Post-Doctoral Training Program for HIV Combination Prevention

UCLA is seeking Ph.D. and M.D. postdoctoral scholars for a T32 training program funded by the National Institute of Mental Health in HIV combination prevention and its comorbid conditions, focusing on novel technologies and reducing health disparities. UCLA offers an intensive and innovative, behaviorally-focused training experience that includes additional academic training, participation in research projects, and professional development, with a strong emphasis on technical writing, grant preparation, and networking. Trainees will have the opportunity to participate in a variety of research in Los Angeles, Asia, Africa and South America; major RCTs involving mental health, substance abuse, behavioral economics and health disparities among high-risk populations; and, novel technologies and research methods, including rapid diagnostic testing and social network analysis.

The specific goals of this multi-year program are to: 1) provide focused, interdisciplinary mentoring in the field of HIV prevention and treatment, especially in terms of conceptualization and design, writing, and project management; 2) engage trainees in two to three years of intensive hands-on research projects under the supervision of faculty mentors experienced in HIV research; 3) support trainees’ development and implementation of their own research projects, leading to their own grant proposals and multiple publications; 4) link trainees to a broad network of HIV researchers, creating opportunities for later career advancement and knowledge of cutting edge research; and, 5) offer the opportunity for one additional course per quarter for one year to remediate deficit skills.

Successful graduates of this training program will:

  • Participate in day-to-day execution of several projects under the mentorship of a faculty member;
  • Present findings in at least one major scientific conference annually and multiple regional conferences;
  • Publish at least two first-authored papers annually in leading journals and collaborate on other peer-reviewed papers; and,
  • Receive a multi-year grant or career development award and an academic position on a topic related to HIV.

Dr. Mary Jane Rotheram-Borus is the Principal Investigator of this T32 program (T32MH109205). Dr. Rotheram-Borus directs the Global Center for Children and Families, which works closely with CHIPTS investigators on multiple collaborative HIV research projects.

Faculty mentors: Any UCLA faculty member working in HIV research is eligible to serve as a faculty mentor for the T32 program. However, T32 trainees are welcome to collaborate on projects with other researchers.

Eligibility: Must be a U.S. citizen or a green-card holder with a Ph.D. or M.D.

To apply: Applications should include a CV, a cover letter describing their interest in the program, where they plan to be in five years, and a shortlist of potential faculty mentors. Please send applications to CCHPublications@mednet.ucla.edu. If you have any questions, please email CCHPublications@mednet.ucla.edu or call (310) 794-8278.